Characterization of murine MGL1 and MGL2 C-type lectins: Distinct glycan specificities and tumor binding propertiesSatwinder Singh, Yvette van Kooyk, Ingeborg Streng‐Ouwehand et al.|Molecular Immunology|2009Cited by 99
Design of neo‐glycoconjugates that target the mannose receptor and enhance TLR‐independent cross‐presentation and Th1 polarizationSatwinder Singh, Yvette van Kooyk, Christian Kurts et al.|European Journal of Immunology|2011Cited by 56
Tumour‐associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responsesSatwinder Singh, Yvette van Kooyk, Ingeborg Streng‐Ouwehand et al.|International Journal of Cancer|2010Cited by 41
Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regressionWendy W. J. Unger, Yvette van Kooyk, Christian T. Mayer et al.|OncoImmunology|2014Cited by 36
Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cellsIngeborg Streng‐Ouwehand, Yvette van Kooyk, Nataschja I. Ho et al.|eLife|2016Cited by 30